☰

Yi T. Koh, Ph.D.

Affiliations: 
2007 Molecular Microbiology & Immunology: Doctor of Philosophy University of Southern California, Los Angeles, CA, United States 
Area:
Immunology, Oncology
Google:
"Yi Koh"
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor
W Martin Kast grad student 2007 USC
 (Effects of androgen ablation and vaccine preparation on cancer vaccine efficacy.)

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Koh YT, Scatizzi JC, Gahan JD, et al. (2013) Role of nucleic acid-sensing TLRs in diverse autoantibody specificities and anti-nuclear antibody-producing B cells. Journal of Immunology (Baltimore, Md. : 1950). 190: 4982-90
Rivas MN, Koh YT, Chen A, et al. (2012) MyD88 is critically involved in immune tolerance breakdown at environmental interfaces of Foxp3-deficient mice. The Journal of Clinical Investigation. 122: 1933-47
Theofilopoulos AN, Gonzalez-Quintial R, Lawson BR, et al. (2010) Sensors of the innate immune system: their link to rheumatic diseases. Nature Reviews. Rheumatology. 6: 146-56
Kono DH, Haraldsson MK, Lawson BR, et al. (2009) Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus. Proceedings of the National Academy of Sciences of the United States of America. 106: 12061-6
Koh YT, Gray A, Higgins SA, et al. (2009) Androgen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization. The Prostate. 69: 571-84
Koh YT, Higgins SA, Weber JS, et al. (2006) Immunological consequences of using three different clinical/laboratory techniques of emulsifying peptide-based vaccines in incomplete Freund's adjuvant. Journal of Translational Medicine. 4: 42
Vatakis DN, Koh YT, McMillan M. (2005) CD4+ T cell epitope affinity to MHC II influences the magnitude of CTL responses elicited by DNA epitope vaccines. Vaccine. 23: 2639-46
See more...